WNT3A and small cell lung carcinoma: We found that Wnt3A, a major canonical Wnt/β-catenin pathway-activating ligand, and R-spondin1, a stem cell-specific Wnt/β-catenin agonist, had critical roles in the long-term maintenance of SCLC tumor organoids (Figure 2A).